Cellular responses to etoposide: Cell death despite cell cycle arrest and repair of DNA damage

Apoptosis

Volumn 15, Issue 2, 2010, Pages 162-172

  Schonn, Ilona ^a   Hennesen, Jana ^a   Dartsch, Dorothee C ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Apoptosis; Cell cycle checkpoint; DNA repair; Etoposide; Homologous recombination; Non homologous end joining

Indexed keywords

ETOPOSIDE; KU ANTIGEN; PROTEIN; PROTEIN KU86; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL STRAIN HT29; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANNEXINS; BLOTTING, WESTERN; CELL CYCLE; CELL DEATH; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; ETOPOSIDE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HT29 CELLS; HUMANS; NEOPLASM PROTEINS; PROPIDIUM; TUMOR STEM CELL ASSAY;

MAMMALIA;

EID: 77949268266     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-009-0440-9     Document Type: Article

References (72)

1. JV Walker JL Nitiss 2002 DNA topoisomerase II as a target for cancer chemotherapy Cancer Invest 20 570 589 10.1081/CNV-120002156 12094551 (Pubitemid 34686351)
2. F Gieseler E Bauer V Nuessler M Clark S Valsamas 1999 Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage Leukemia 13 1859 1863 10.1038/sj/leu/2401570 10557063
3. Y Wang R Zhou J Liliemark A Gruber S Lindemalm F Albertioni E Liliemark 2001 In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia Leuk Res 25 133 140 10.1016/S0145-2126(00)00103-X 10.1016/S0145- 2126(00)00103-X 11166828 (Pubitemid 32141116)
4. BC Baguley LR Ferguson 1998 Mutagenic properties of topoisomerase- targeted drugs Biochim Biophys Acta 1400 213 222 10.1016/S0167-4781(98)00137-7 9748584 (Pubitemid 28475105)
5. CA Felix 2001 Leukemias related to treatment with DNA topoisomerase II inhibitors Med Pediatr Oncol 36 525 535 10.1002/mpo.1125 11340607 (Pubitemid 32336557)
6. CA Felix CP Kolaris N Osheroff 2006 Topoisomerase II and the etiology of chromosomal translocations DNA Repair (Amst) 5 1093 1108 10.1016/j.dnarep.2006. 05.031 10.1016/j.dnarep.2006.05.031 (Pubitemid 44291622)
7. AR Mistry CA Felix RJ Whitmarsh A Mason A Reiter B Cassinat A Parry C Walz JL Wiemels MR Segal L Ades IA Blair N Osheroff AJ Peniket M Lafage-Pochitaloff NC Cross C Chomienne E Solomon P Fenaux D Grimwade 2005 DNA topoisomerase II in therapy-related acute promyelocytic leukemia N Engl J Med 352 1529 1538 10.1056/NEJMoa042715 15829534 (Pubitemid 40517093)
8. A Ohshima I Miura A Chubachi K Hashimoto T Nimura S Utsumi N Takahashi Y Hayashi M Seto R Ueda AB Miura 1996 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone Am J Hematol 53 264 266 10.1002/(SICI)1096-8652(199612)53:4<264: :AID-AJH12>3.0.CO;2-C 8948668 (Pubitemid 26419717)
9. C Sandoval CH Pui LC Bowman D Heaton CA Hurwitz SC Raimondi FG Behm DR Head 1993 Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation J Clin Oncol 11 1039 1045 8388919
10. A Schiavetti G Varrasso P Maurizi MA Castello 2001 Two secondary leukemias among 15 children given oral etoposide Med Pediatr Oncol 37 148 149 10.1002/mpo.1187 11496357 (Pubitemid 32738080)
11. Y Zhang JD Rowley 2006 Chromatin structural elements and chromosomal translocations in leukemia DNA Repair (Amst) 5 1282 1297 10.1016/j.dnarep.2006. 05.020 10.1016/j.dnarep.2006.05.020 (Pubitemid 44291613)
12. LF Liu TC Rowe L Yang KM Tewey GL Chen 1983 Cleavage of DNA by mammalian DNA topoisomerase II J Biol Chem 258 15365 15370 6317692
13. T Tanaka HD Halicka F Traganos K Seiter Z Darzynkiewicz 2007 Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase Cell Cycle 6 371 376 17297310
14. DC Dartsch F Gieseler 2007 Repair of idarubicin-induced DNA damage: a cause of resistance? DNA Repair (Amst) 6 1618 1628 10.1016/j.dnarep.2007.05.007 10.1016/j.dnarep.2007.05.007 (Pubitemid 47600106)
15. JR Fan AL Peng HC Chen SC Lo TH Huang TK Li 2008 Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses DNA Repair (Amst) 7 452 463 10.1016/j.dnarep.2007.12.002 10.1016/j.dnarep.2007. 12.002
16. J Agner J Falck J Lukas J Bartek 2005 Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway Exp Cell Res 302 162 169 10.1016/j.yexcr.2004.08.035 10.1016/j.yexcr.2004.08.035 15561098 (Pubitemid 39550459)
17. AJ Hartlerode R Scully 2009 Mechanisms of double-strand break repair in somatic mammalian cells Biochem J 423 157 168 10.1042/BJ20090942 19772495
18. B Pardo B Gomez-Gonzalez A Aguilera 2009 DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship Cell Mol Life Sci 66 1039 1056 10.1007/s00018-009-8740-3 10.1007/s00018-009-8740-3 19153654
19. M Shrivastav LP De Haro JA Nickoloff 2008 Regulation of DNA double-strand break repair pathway choice Cell Res 18 134 147 10.1038/cr.2007.111 10.1038/cr.2007.111 18157161
20. E Sonoda H Hochegger A Saberi Y Taniguchi S Takeda 2006 Differential usage of non-homologous end-joining and homologous recombination in double strand break repair DNA Repair (Amst) 5 1021 1029 10.1016/j.dnarep.2006.05.022 10.1016/j.dnarep.2006.05.022 (Pubitemid 44291617)
21. J Flygare F Benson D Hellgren 1996 Expression of the human RAD51 gene during the cell cycle in primary human peripheral blood lymphocytes Biochim Biophys Acta 1312 231 236 10.1016/0167-4889(96)00040-7 8703992 (Pubitemid 26246521)
22. Z Mao M Bozzella A Seluanov V Gorbunova 2008 DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells Cell Cycle 7 2902 2906 18769152
23. JM Daley TE Wilson 2005 Rejoining of DNA double-strand breaks as a function of overhang length Mol Cell Biol 25 896 906 10.1128/MCB.25.3.896-906. 2005 10.1128/MCB.25.3.896-906.2005 15657419 (Pubitemid 40165799)
24. L Hansen C Lundin M Spang-Thomsen L Petersen T Helleday 2003 The role of Rad51 in etoposide (VP-16) resistance in small cell lung cancer Int J Cancer 105 472 479 10.1002/ijc.11106 10.1002/ijc.11106 12712436 (Pubitemid 36578549)
25. G Iliakis H Wang AR Perrault W Boecker B Rosidi F Windhofer W Wu J Guan G Terzoudi G Pantelias 2004 Mechanisms of DNA double strand break repair and chromosome aberration formation Cytogenet Genome Res 104 14 20 10.1159/000077461 10.1159/000077461 15162010 (Pubitemid 38721048)
26. H Wang Z-C Zeng T Bui E Sonoda M Takata S Takeda G Iliakis 2001 Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group Oncogene 20 2212 2224 10.1038/sj.onc.1204350 11402316 (Pubitemid 32531279)
27. MT Fiorenza A Bevilacqua S Bevilacqua F Mangia 2001 Growing dictyate oocytes, but not early preimplantation embryos, of the mouse display high levels of DNA homologous recombination by single-strand annealing and lack DNA nonhomologous end joining Dev Biol 233 214 224 10.1006/dbio.2001.0199 11319870 (Pubitemid 32411306)
28. W Goedecke M Eijpe HH Offenberg M van Aalderen C Heyting 1999 Mre11 and Ku70 interact in somatic cells, but are differentially expressed in early meiosis Nat Genet 23 194 198 10.1038/13821 10.1038/13821 10508516 (Pubitemid 29455392)
29. G Hamer HL Roepers-Gajadien A van Duyn-Goedhart IS Gademan HB Kal PP van Buul T Ashley DG de Rooij 2003 Function of DNA-protein kinase catalytic subunit during the early meiotic prophase without Ku70 and Ku86 Biol Reprod 68 717 721 10.1095/biolreprod.102.008920 12604618 (Pubitemid 36245813)
30. K Hopfner C Putnam J Tainer 2002 DNA double-strand break repair from head to tail Curr Opin Struct Biol 12 115 122 10.1016/S0959-440X(02)00297-X 10.1016/S0959-440X(02)00297-X 11839498 (Pubitemid 34142729)
31. K Khanna S Jackson 2001 DNA double-strand breaks: signaling, repair and the cancer connection Nat Genet 27 247 254 10.1038/85798 10.1038/85798 11242102 (Pubitemid 32201842)
32. E Van Dyck A Stasiak A Stasiak S West 1999 Binding of double strand breaks in DNA by human Rad52 protein Nature 398 728 731 10.1038/19560 10.1038/19560 10227297 (Pubitemid 29197653)
33. W-D Heyer X Li M Rolfsmeier X-P Zhang 2006 Rad54: the Swiss army knife of homologous recombination? Nucl Acid Res 34 4115 4125 10.1093/nar/gkl481 10.1093/nar/gkl481 (Pubitemid 44542190)
34. PJ Morin B Vogelstein KW Kinzler 1996 Apoptosis and APC in colorectal tumorigenesis Proc Natl Acad Sci USA 93 7950 7954 10.1073/pnas.93.15.7950 8755583 (Pubitemid 26277145)
35. A Aydiner H Koyuncu F Tas E Topuz R Disci 2000 Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day Int J Clin Pharm Res 20 21 30
36. S Eksborg H-S Strandler F Edsmyr I Näslund P Tahvanainen 1985 Pharmacokinetic study of IV infusions of adriamycin Eur J Clin Pharmacol 28 205 212 10.1007/BF00609693 3987800 (Pubitemid 15143785)
37. R Greene J Collins J Jenkins J Speyer C Myers 1983 Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols Cancer Res 43 3417 3421 6850648
38. J Holthuis P Postmus W Van Oort B Hulshoff H Verleun D Sleijfer N Mulder 1986 Pharmacokinetics of high dose etoposide (VP 16-213) Eur J Cancer Clin Oncol 22 1149 1155 10.1016/0277-5379(86)90315-9 3643849 (Pubitemid 17178712)
39. K Mross U Mayer K Hamm K Burk D Hossfeld 1990 Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans Eur J Clin Pharmacol 39 507 513 10.1007/BF00280945 2076745
40. A van der Gaast M Vlastuin T Kok T Splinter 1992 What is the optimal dose and duration of treatment with etoposide ? II. Comparative pharmacokinetic study of three schedules: 1 × 100 mg, 2 × 50 mg, and 4 × 25 mg of oral etoposide daily for 21 days Semin Oncol 19 8 12 1488657
41. G Zhu R Gilchrist N Borley H Chng M Morgan J Marshall R Camplejohn G Muir I Hart 2004 Reduction of TSG101 protein has a negative impact on tumor cell growth Int J Cancer 109 541 547 10.1002/ijc.20014 10.1002/ijc.20014 14991575 (Pubitemid 38339644)
42. D Dartsch A Schaefer S Boldt W Kolch H Marquardt 2002 Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis Apoptosis 7 537 548 10.1023/A:1020647211557 10.1023/A: 1020647211557 12370496 (Pubitemid 35334448)
43. N Singh M McCoy R Tice E Schneider 1988 A simple technique for quantitation of low levels of DNA damage in individual cells Exp Cell Res 175 184 191 10.1016/0014-4827(88)90265-0 10.1016/0014-4827(88)90265-0 3345800
44. AR Collins AA Oscoz G Brunborg I Gaivao L Giovannelli M Kruszewski CC Smith R Stetina 2008 The comet assay: topical issues Mutagenesis 23 143 151 10.1093/mutage/gem051 18283046
45. EL Baldwin N Osheroff 2005 Etoposide, topoisomerase II and cancer Curr Med Chem Anticancer Agents 5 363 372 10.2174/1568011054222364 16101488 (Pubitemid 40974810)
46. G Chen L Yang T Rowe B Halligan K Tewey L Liu 1984 Nonintercalative antitumor drugs interfere with the breakage reunion reaction of mammalian DNA topoisomerase II J Biol Chem 259 21 13560 13566 6092381 (Pubitemid 15221834)
47. K Hande 1998 Etoposide: four decades of development of a topoisomerase II inhibitor Eur J Cancer 34 1514 1521 10.1016/S0959-8049(98)00228-7 10.1016/S0959-8049(98)00228-7 9893622 (Pubitemid 28446331)
48. JM Brown G Wilson 2003 Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? Cancer Biol Ther 2 477 490 14614312
49. JM Brown BG Wouters 1999 Apoptosis, p53, and tumor cell sensitivity to anticancer agents Cancer Res 59 1391 1399 10197600
50. C Lo Nigro E Arnolfo E Taricco A Fruttero EG Russi F Lucio S Ribero A Comino M Merlano S Ungari 2007 The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death Anticancer Drugs 18 659 667 10.1097/CAD.0b013e328087388f 17762394 (Pubitemid 47343658)
51. J Russell CC Ling 2003 Studies with cytotoxic agents suggest that apoptosis is not a major determinant of clonogenic death in neuroblastoma cells Eur J Cancer 39 2234 2238 10.1016/S0959-8049(03)00488-X 14522384 (Pubitemid 37297751)
52. R Bertrand M Sarang J Jenkin D Kerrigan Y Pommier 1991 Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression Cancer Res 51 6280 6285 1933888
53. F Gieseler V Nussler T Brieden J Kunze S Valsamas 1998 Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death Int J Clin Pharmacol Ther 36 25 28 9476145
54. TK Li LF Liu 2001 Tumor cell death induced by topoisomerase-targeting drugs Annu Rev Pharmacol Toxicol 41 53 77 10.1146/annurev.pharmtox.41.1.53 10.1146/annurev.pharmtox.41.1.53 11264450 (Pubitemid 32385882)
55. BH Long ST Musial MG Brattain 1985 Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide Cancer Res 45 3106 3112 3839166
56. S Chatterjee D Trivedi S Petzold N Berger 1990 Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines Cancer Res 50 2713 2718 2328496
57. PA Sung J Libura C Richardson 2006 Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions DNA Repair (Amst) 5 1109 1118 10.1016/j.dnarep.2006.05.018 (Pubitemid 44291612)
58. SM Chuang LH Wang JH Hong YW Lin 2008 Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo[a]pyrene-exposed human lung cancer cells Toxicol Appl Pharmacol 230 290 297 10.1016/j.taap.2008. 03.001 10.1016/j.taap.2008.03.001 18430445
59. D Averbeck S Averbeck 1998 DNA photodamage, repair, gene induction and genotoxicity following exposures to 254 nm UV and 8-methoxypsoralen plus UVA in a eukaryotic cell system Photochem Photobiol 68 289 295 10.1111/j.1751-1097. 1998.tb09683.x 10.1111/j.1751-1097.1998.tb09683.x 9747584
60. Y Cohen M Dardalhon D Averbeck 2002 Homologous recombination is essential for RAD51 up-regulation in Saccharomyces cerevisiae following DNA crosslinking damage Nucleic Acids Res 30 1224 1232 10.1093/nar/30.5.1224 11861915
61. HL Klein 2008 The consequences of Rad51 overexpression for normal and tumor cells DNA Repair (Amst) 7 686 693 10.1016/j.dnarep.2007.12.008 10.1016/j.dnarep.2007.12.008
62. P Karran 2000 DNA double strand break repair in mammalian cells Curr Opin Genet Dev 10 144 150 10.1016/S0959-437X(00)00069-1 10.1016/S0959-437X(00)00069- 1 10753787 (Pubitemid 30182246)
63. Z Han N Malik T Carter WH Reeves JH Wyche EA Hendrickson 1996 DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease J Biol Chem 271 25035 25040 10.1074/jbc.271.40.25035 10.1074/jbc.271.40.25035 8798786 (Pubitemid 26333263)
64. S Kim D Kim J Han C Jeong B Chung C Kang G Li 1999 Ku autoantigen affects the susceptibility to anticancer drugs Cancer Res 59 4012 4017 10463600
65. G Smith S Jackson 1999 The DNA-dependent protein kinase Genes Dev 13 916 934 10.1101/gad.13.8.916 10215620
66. Q Song SP Lees-Miller S Kumar Z Zhang DW Chan GC Smith SP Jackson ES Alnemri G Litwack KK Khanna MF Lavin 1996 DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis EMBO J 15 3238 3246 8670824
67. P Zhu D Zhang D Chowdhury D Martinvalet D Keefe L Shi J Lieberman 2006 Granzyme A, which causes single-stranded DNA damage, targets the double-strand break repair protein Ku70 EMBO Rep 7 431 437 10.1038/sj.embor.7400622 16440001
68. V Gama T Yoshida JA Gomez DP Basile LD Mayo AL Haas S Matsuyama 2006 Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis Exp Cell Res 312 488 499 10.1016/j.yexcr.2005.11.016 16368436 (Pubitemid 41804113)
69. SE Lee JK Moore A Holmes K Umezu RD Kolodner JE Haber 1998 Saccharomyces Ku70, mre11/rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage Cell 94 399 409 10.1016/S0092-8674(00)81482-8 9708741 (Pubitemid 28376083)
70. Y Zhang ML Hefferin L Chen EY Shim HM Tseng Y Kwon P Sung SE Lee AE Tomkinson 2007 Role of Dnl4-Lif1 in nonhomologous end-joining repair complex assembly and suppression of homologous recombination Nat Struct Mol Biol 14 639 646 10.1038/nsmb1261 10.1038/nsmb1261 17589524 (Pubitemid 47037068)
71. M Frank-Vaillant S Marcand 2002 Transient stability of DNA ends allows nonhomologous end joining to precede homologous recombination Mol Cell 10 1189 1199 10.1016/S1097-2765(02)00705-0 10.1016/S1097-2765(02)00705-0 12453425 (Pubitemid 35453835)
72. G Ira A Pellicioli A Balijja X Wang S Fiorani W Carotenuto G Liberi D Bressan L Wan NM Hollingsworth JE Haber M Foiani 2004 DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1 Nature 431 1011 1017 10.1038/nature02964 10.1038/nature02964 15496928 (Pubitemid 39434425)